CALEB RAINE: Open Payments
NPI 1699926899 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 12 payments from 7 companies in 2025. Trend: 2023 $336 · 2024 $217 · 2025 $904
Food & beverage: $835Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 3 | $335 |
| Adaptive Biotechnologies Corporation | 3 | $135 |
| Regeneron Healthcare Solutions, Inc. | 1 | $97 |
| PFIZER INC. | 2 | $95 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $88 |
| Legend Biotech USA Inc. | 1 | $85 |
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
Products named: DARZALEX, CARVYKTI, clonoSEQ, LYNOZYFIC, ELREXFIO, SYLVANT, IMFINZI.
Industry payments across GA — which companies pay providers there.
